Anti-Infective Agents Market Set for US$176.8 Billion by 2031, Growing at 3.2% CAGR
Infectious diseases remain a persistent challenge for healthcare systems worldwide, keeping anti-infective medicines at the center of pharmaceutical demand. From antibiotics and antivirals to antifungal and antiparasitic treatments, these therapies support the management of infections across hospitals, outpatient settings, and community healthcare. At the same time, the industry is undergoing an important transformation. Drug-resistant pathogens, … Read more